Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Virgen de las Nieves (221)

2024

  1. Analysis of HLA Alleles in Different Cohorts of Patients Infected by L. infantum from Southern Spain

    International Journal of Molecular Sciences, Vol. 25, Núm. 15

  2. Follow-up of immune response in patients with common variable immunodeficiency following SARS-CoV-2 vaccination

    Clinical and Experimental Immunology, Vol. 217, Núm. 3, pp. 253-262

  3. Possible Role of Cytomegalovirus in Gastric Cancer Development and Recurrent Macrolide-Resistant Campylobacter jejuni Infection in Common Variable Immunodeficiency: A Case Report and Literature Discussion

    Microorganisms, Vol. 12, Núm. 6

2023

  1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248

  2. Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  3. GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  4. Human adipose tissue as a major reservoir of cytomegalovirus-reactive T cells

    Frontiers in Immunology, Vol. 14

  5. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  6. Microbiome and multiple sclerosis

    Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (Elsevier), pp. 73-88

  7. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2022

  1. A polygenic risk score for multiple myeloma risk prediction

    European Journal of Human Genetics, Vol. 30, Núm. 4, pp. 474-479

  2. Autophagy in Hematological Malignancies

    Cancers, Vol. 14, Núm. 20

  3. Common Variable Immunodeficiency Associated with a De Novo IKZF1 Variant and a Low Humoral Immune Response to the SARS-CoV-2 Vaccine

    Journal of Clinical Medicine, Vol. 11, Núm. 9

  4. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 31, Núm. 9, pp. 1863-1866

  5. HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine

    Vaccines, Vol. 10, Núm. 3

  6. Incidence, Management Experience and Characteristics of Patients with Giardiasis and Common Variable Immunodeficiency

    Journal of Clinical Medicine, Vol. 11, Núm. 23

  7. Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  8. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients

    Journal of Microbiology, Immunology and Infection, Vol. 55, Núm. 3, pp. 421-427

  9. Study of humoral and cellular immunity in vaccinated with mRNA-1273

    APMIS, Vol. 130, Núm. 5, pp. 261-269

  10. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10